WallStSmart

Pfizer Inc (PFE)vsVodafone Group PLC ADR (VOD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Pfizer Inc generates 61% more annual revenue ($62.58B vs $38.78B). PFE leads profitability with a 12.4% profit margin vs -11.4%. VOD appears more attractively valued with a PEG of 0.61. VOD earns a higher WallStSmart Score of 51/100 (C-).

PFE

Hold

49

out of 100

Grade: D+

Growth: 2.0Profit: 6.5Value: 4.7Quality: 4.8
Piotroski: 3/9

VOD

Buy

51

out of 100

Grade: C-

Growth: 6.0Profit: 3.5Value: 6.7Quality: 5.0
Piotroski: 6/9Altman Z: -0.58
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PFESignificantly Overvalued (-194.9%)

Margin of Safety

-194.9%

Fair Value

$9.25

Current Price

$27.28

$18.03 premium

UndervaluedFair: $9.25Overvalued

Intrinsic value data unavailable for VOD.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PFE4 strengths · Avg: 8.3/10
Market CapQuality
$153.36B9/10

Large-cap with strong market position

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
23.9%8/10

Strong operational efficiency at 23.9%

Free Cash FlowQuality
$4.50B8/10

Generating 4.5B in free cash flow

VOD2 strengths · Avg: 8.0/10
PEG RatioValuation
0.618/10

Growing faster than its price suggests

Free Cash FlowQuality
$2.05B8/10

Generating 2.0B in free cash flow

Areas to Watch

PFE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
13.772/10

Expensive relative to growth rate

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

EPS GrowthGrowth
-21.3%2/10

Earnings declined 21.3%

VOD4 concerns · Avg: 1.8/10
Return on EquityProfitability
-6.6%2/10

ROE of -6.6% — below average capital efficiency

EPS GrowthGrowth
-15.4%2/10

Earnings declined 15.4%

Altman Z-ScoreHealth
-0.582/10

Distress zone — elevated risk

Profit MarginProfitability
-11.4%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : PFE

The strongest argument for PFE centers on Market Cap, Price/Book, Operating Margin.

Bull Case : VOD

The strongest argument for VOD centers on PEG Ratio, Free Cash Flow. PEG of 0.61 suggests the stock is reasonably priced for its growth.

Bear Case : PFE

The primary concerns for PFE are Piotroski F-Score, PEG Ratio, Revenue Growth.

Bear Case : VOD

The primary concerns for VOD are Return on Equity, EPS Growth, Altman Z-Score.

Key Dynamics to Monitor

PFE profiles as a declining stock while VOD is a turnaround play — different risk/reward profiles.

PFE carries more volatility with a beta of 0.41 — expect wider price swings.

VOD is growing revenue faster at 7.3% — sustainability is the question.

PFE generates stronger free cash flow (4.5B), providing more financial flexibility.

Bottom Line

VOD scores higher overall (51/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Pfizer Inc

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.

Visit Website →

Vodafone Group PLC ADR

COMMUNICATION SERVICES · TELECOM SERVICES · USA

Vodafone Group Plc is engaged in telecommunications services in Europe and internationally. The company is headquartered in Newbury, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?